• Home
  • >
  • J B Chemicals Pharmaceuticals Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/BlinkxSearch/initials/j.svg Logo

J B Chemicals Pharmaceuticals Ltd Financial Statement

J B Chemicals Pharmaceuticals Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue825.3806.71843.6
Operating Expense614.15585.41601.92
Net Profit125.85127.92145.02
Net Profit Margin15.2515.8617.19
Earning Per Share8.118.259.36
EBIDTA201.81207.72228.41
Effective Tax Rate13.2215.7717.56

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

J B Chemicals Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual3,149.282,424.242,042.52
Operating Expenses Annual2,453.531,880.791,482.11
Operating Profit Annual705.69582.68672.79
Interest Annual36.055.127.24
Depreciation114.4172.6668.67
Net Profit Annual409.84385.36447.96
Tax Annual145.23118.86148.36

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

J B Chemicals Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning56.5422.4725.75
Cash Flow from Operations625.61170.13314.78
Cash Flow from Investing-961.762.32-230.64
Cash Flow from Financing356.54-138.39-87.42
Cash Flow at the End76.9356.5422.47

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

J B Chemicals Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)22.4124.0429.88
PBIT Margin (%)18.7821.0426.52
PBT Margin (%)18.2116.4922.57
Net PROFIT Margin (%)13.4816.4823.63
Return On Networth / Equity (%)17.7719.5824.75
Return On Networth /Employed(%)22.4125.0132.32
Return On Assets (%)16.0519.6228.83
Total Debt / Equity(X)0.130.020.02
Asset Turnover Ratio (%)1.191.191.22

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

J B Chemicals Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual1,911.751,281.76633.65
Total Current Assets Annual1,528.031,253.161,552.6
Non Current Assets Annual2,025.841,354.24685.51
Total Shareholders Funds Annual2,480.352,134.121,809.72
Total Assets Annual3,553.872,607.42,238.12

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

J B Chemicals Pharmaceuticals Ltd Earning Calls
Mar 2024
EPS beaten by 1.11 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, J B Chemicals Pharmaceuticals Ltd has a market capitalization of 25,598.61 Cr. Value Research classifies it as a Large-Cap company.

Yes, J B Chemicals Pharmaceuticals Ltd is debt-free with a debt-to-equity ratio of 0.13.

In FY 2023, J B Chemicals Pharmaceuticals Ltd recorded a total revenue of approximately 3,484.18 Cr marking a significant milestone in the company's financial performance.

J B Chemicals Pharmaceuticals Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.2% annually, respectively..

J B Chemicals Pharmaceuticals Ltd's current PE ratio is 46.32.

J B Chemicals Pharmaceuticals Ltd's ROCE averaged 22.2% from the FY ending March 2022 to 2024, with a median of 23.3%. It peaked at 24.1% in March 2024, reflecting strong capital efficiency over the period..

J B Chemicals Pharmaceuticals Ltd's latest EBIT is Rs. 795.84 Cr, surpassing the average EBIT of Rs. 632.38 Cr over the 5 years..